TwinBeech Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
TwinBeech Capital's IMVT Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Immunovant (IMVT) in Q3 2026: 25,100 shares worth $848K. The stake represents 0.2% of the portfolio and ranks #151 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in IMVT as recently as Q1 2025.
TwinBeech Capital first reported a position in IMVT in Q2 2023 and has held it in 6 quarters since. The position peaked at $2.08M in Q2 2023. 229 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- TwinBeech Capital held 25,100 shares of Immunovant worth $848K as of Q3 2026.
- Immunovant was a new TwinBeech Capital position in Q3 2026.
- Immunovant made up 0.2% of TwinBeech Capital's portfolio in Q3 2026, its #151 holding.
- TwinBeech Capital first reported a position in Immunovant in Q2 2023 and has held it in 6 quarters since.
- TwinBeech Capital's Immunovant position peaked at $2.08M in Q2 2023.
- 229 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.